Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Helicobacter pylori: a review.

D W Wood1, K P Block

  • 1Department of Medicine, Gastroenterology Division, University of Wisconsin, Madison 53792, USA.

American Journal of Therapeutics
|March 31, 1999
PubMed
Summary

Helicobacter pylori (H. pylori) infection is linked to stomach issues like gastritis and ulcers. This review examines current and future pharmacological treatments for H. pylori, focusing on efficacy and cost.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

High-throughput purification of recombinant proteins using self-cleaving intein tags.

Analytical biochemistry·2016
Same author

Homoserine lactone-mediated gene regulation in plant-associated bacteria.

Annual review of phytopathology·2004
Same author

The genome of the natural genetic engineer Agrobacterium tumefaciens C58.

Science (New York, N.Y.)·2001
Same author

Technology status evaluation report. Transmission of infection by gastrointestinal endoscopy. May 2001.

Gastrointestinal endoscopy·2001
Same author

Technology Status Evaluation report. Colonoscopy preparations. May 2001.

Gastrointestinal endoscopy·2001
Same author

Technology status evaluation report. Endoscopic hemostatic devices. May 2001.

Gastrointestinal endoscopy·2001

Area of Science:

  • Microbiology and Infectious Diseases
  • Gastroenterology
  • Pharmacology

Background:

  • Helicobacter pylori, a gram-negative bacterium discovered in 1982, is associated with significant gastrointestinal and non-gastrointestinal disorders.
  • H. pylori infection is a primary cause of gastritis, peptic ulcer disease, and gastric carcinoma.
  • Understanding the epidemiology, transmission, and virulence factors of H. pylori is crucial for effective management.

Purpose of the Study:

  • To review the pharmacological basis of current and emerging treatment options for H. pylori infections.
  • To evaluate the efficacy and economic considerations of various antimicrobial therapies.
  • To provide an overview of diagnostic tools and potential future interventions like vaccination.

Main Methods:

  • Literature review of pharmacological treatments for H. pylori.
  • Analysis of clinical efficacy data for antimicrobial regimens.
  • Examination of economic factors influencing treatment choices.
  • Discussion of diagnostic modalities and future therapeutic strategies.

Main Results:

  • Established antimicrobial treatments significantly improve cure rates for H. pylori-associated gastritis and ulcers.
  • Treatment reduces the recurrence rates of peptic ulcer disease.
  • Various diagnostic tools are available for H. pylori detection.
  • Vaccination strategies are under development for high-endemic regions.

Conclusions:

  • Effective pharmacological treatments are available for H. pylori infections, improving patient outcomes.
  • Economic considerations play a role in selecting appropriate treatment regimens.
  • Ongoing research into diagnostics and vaccines promises enhanced future management of H. pylori.

Related Experiment Videos